Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite Using Citrate- vs Acetate-based Dialysate
Sponsor: Centre Hospitalier de Bethune
Summary
During intermittent hemodialysis (IHD), the occurrence of intradialytic hemodynamic instability (IHI) is frequent in ICU and impacted morbidity and mortality. Bicarbonate dialysate buffer improves hemodynamic tolerance compared to acetate dialysate buffer. However, bicarbonate dialysate buffer still contains a lower concentration of acetate, which could contribute to hemodynamic instability. Recently, citrate-based dialysate in bicarbonate hemodialysis instead of acetate have been proposed. They have the appropriate authorizations for routine use. The aim of this study is to compare acetate- vs citrate-based dialysate in terms of hemodynamic tolerance and effectiveness.
Official title: Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite (ICU) Using Citrate- vs Acetate-based Dialysate
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2023-12-07
Completion Date
2027-07
Last Updated
2026-01-06
Healthy Volunteers
No
Conditions
Interventions
ACETATE based dialysate
Intermittent hemodialysis with an acetate based dialysate.
CITRATE based dialysate
Intermittent hemodialysis with an citrate based dialysate.
Locations (4)
Centre Hospitalier Béthune
Béthune, France
CHU
Caen, France
Centre Hospitalier Universitaire de Dijon
Dijon, France
CHRU Nancy
Nancy, France